FDA OKs vitamin C trial for cancer

Jan 12, 2007

Federal approval of a clinical trial on intravenous vitamin C as a cancer treatment lends credence to alternative cancer care, U.S. researchers said.

Cancer Treatment Centers of America said it won Food and Drug Administration approval to begin the trial, a move the Illinois-based hospital group said adds credibility to its research into alternative methods for cancer medical care, the Chicago Tribune said Thursday. It is the first FDA-approved trial for CTCA.

Just a few patients will be eligible, said Christopher Lis, the firm's vice president of research and development.

"Only patients who have exhausted all other conventional treatment options are eligible to receive the therapy," Lis said.

The first phase will be to determine the optimal dose for the patients and to learn whether the treatment is safe and can be tolerated, Lis said. Additional studies over several years would be needed to demonstrate whether it is effective.

Earlier studies conducted with vitamin C supplements administered orally did not to demonstrate a clinical benefit to cancer patients.

Cancer Treatment Centers, with facilities in Illinois, Pennsylvania and Oklahoma, provides traditional and alternative treatment for cancer patients.

Copyright 2007 by United Press International

Explore further: Prognostic factors identified for peripheral squamous cell carcinomas of the lung

add to favorites email to friend print save as pdf

Related Stories

Quantum effects in nanometer-scale metallic structures

39 minutes ago

Plasmonic devices combine the 'super speed' of optics with the 'super small' of microelectronics. These devices exhibit quantum effects and show promise as possible ultrafast circuit elements, but current ...

Why has Halloween infiltrated Australian culture?

49 minutes ago

Halloween appears to have infiltrated Australian culture, and according to a University of Adelaide researcher, the reason for its increasing popularity could run much deeper than Americanisation.

Historical comet-landing site is looking for a name

49 minutes ago

The Rosetta mission reaches a defining moment on Wednesday November 12, when its lander, Philae, is released. After about seven hours of descent, Philae will arrive on the surface of Comet 67P Churyumov-Gerasimenko. ...

Research unlocks potential of super-compound

49 minutes ago

Researchers at The University of Western Australia's have discovered that nano-sized fragments of graphene - sheets of pure carbon - can speed up the rate of chemical reactions.

Recommended for you

Video: Is that double mastectomy really necessary?

Oct 24, 2014

When Angeline Vuong, 27,was diagnosed with cancer in one breast earlier this year, her first reaction was "A DOUBLE MASTECTOMY. NOW. " Turns out, she's far from alone: a recent JAMA study of 190,000 breast cancer cases in ...

User comments : 0